Skip to main content

ORIGINAL RESEARCH article

Front. Genet.
Sec. Cancer Genetics and Oncogenomics
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1425591

Identification of plasma exosomal lncRNA as a biomarker for early diagnosis of gastric cancer

Provisionally accepted
  • 1 College of Medicine, Yangzhou University,, Yangzhou, China
  • 2 Institute of Epigenetics and Epigenomics, College of Animal Science and technology, Yangzhou University, Yangzhou, Jiangsu Province, China
  • 3 Yangzhou Center for Disease Control and Prevention, Yangzhou, Jiangsu Province, China
  • 4 Yangzhou Maternity and Child Health Care Hospital, Yangzhou, Jiangsu Province, China
  • 5 Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

    Background, there were about 1,090,000 gastric cancer (GC) cases in 2020 in China.The incidence and mortality rates ranked the fifth and third among all kinds of cancers in China. Early diagnosis plays an important role in the treatment and prognosis of gastric cancer. In recent years, noninvasive diagnosis, especially plasma exosome lncRNAs, has become a promissing biomarkers with high specificity and sensitivity for early diagnosis of cancers. Methods, in this study, plasma exosomes of patients with early gastric cancer were extracted efficiently by affinity membrane separation technology, including affinity adsorption, elution, affinity membrane regeneration and other steps. After identified by electron microscopy observation, particle size analysis and Western-blot verification, the lncRNAs in the exosomes were extracted and were analysized by high-throughput RNA sequencing(RNA-Seq). The differentially expressed lncRNAs were verified by RT-qPCR in 93 patients with early gastric cancer and 49 normal controls. Results, electron microscopy, particle size analysis and Western blot showed that exosomes were successfully isolated from plasma. RNA-Seq results show that 76 lncRNAs were up-regulated and 260 lncRNAs were down regulated in plasma exosomes of early gastric cancer patients compared with normal controls. RT-qPCR analysis indicated that a total of 6 lncRNAs were significantly and differentially expressed in gastric cancer patients compared to normal controls, with 2 (lncmstrg. 1319590,Lncmstrg. 2312697) highly expressed and 4 lowly expressed (lncmstr-g.1004024.1, lncmstrg. 2441832.8, lncmstrg.315376.1, lncmstrg. 907985.2,)(p < 0.05). The survival curve analysis indicated that lncmstrg.2441832.8 and lncmstrg.2312697 had higher sensitivity and specificity for the diagnosis of gastric cancer, respectively and AUC curve areas were 0.6211 and 0.631, p < 0.05, respectively, which were greater than the traditional clinical detection indexes CEA (0.61) and AFP (0.57). When combined lncmstrg.2441832.8 and lncmstrg.2312697 in gastric cancer diagnosis, AUC curve area reached 0.73, which was greater than CA199 (0.71). Conclusion, lncmstrg.2441832.8 and lncmstrg.2312697 may be a potential and promissing biomarkers for early diagnosis of gastric cancer.

    Keywords: gastric cancer, exosome, lncRNA, diagnosis biomarker, early diagonsis

    Received: 30 Apr 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 Wei, Hu, Yuan, Zhao, Zhu, Guo and Cui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hengmi Cui, Institute of Epigenetics and Epigenomics, College of Animal Science and technology, Yangzhou University, Yangzhou, Jiangsu Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.